# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Finding useful health information on the Internet can be difficult, but we’re here to help. This page gathers quality information from trusted sources. You can learn more about the disease, visit handpicked websites, and find resources to help you in your daily life. Need more information? Click the menu on the left to find more!



Get Update

Clinical Trials

This information is provided by ClinicalTrials.gov

Search Clinical Trials
Displaying 41-50 of 4047 results.
Study of IDN-6556 in Patients With Severe Alcoholic Hepatitis and Contraindications to Steroid Therapy
Status: Terminated
Last Changed: Nov 04, 2016
First Received: Jul 31, 2013
Disease(s): Alcoholic Hepatitis
Intervention(s): IDN-6556, Placebo
Locations: Indiana University, Indianapolis, Indiana, United States
Mayo Clinic, Rochester, Minnesota, United States
Virginia Commonwealth University, Richmond, Virginia, United States
Hepatitis C: Grading and Staging by MR
Status: Completed
Last Changed: Mar 18, 2010
First Received: Apr 25, 2003
Disease(s): Hepatitis
Locations: Thomas Jefferson University Hospital, Philadelphia, Pennsylvania, United States
Hepatitis B Booster Study in Adolescence
Status: Completed
Last Changed: Mar 21, 2019
First Received: Jun 23, 2014
Disease(s): Hepatitis B
Intervention(s): EngerixB, GlaxoSmithKline Vaccines
Locations: Vaccine Evaluation Center (University of BC at Children's Hospital), Vancouver, British Columbia, Canada
Reversal of Hepatic Impairment in Patients With Hepatitis C Virus (HCV) and Early Decompensation of Cirrhosis
Status: Active, not recruiting
Last Changed: Jan 23, 2020
First Received: May 27, 2015
Disease(s): Hepatitis C
Intervention(s): Simeprivir (SMV), Sofosbuvir (SOF), Ribavirin (RBV)
Locations: University of Colorado Denver (Leprino Building), Denver, Colorado, United States
Immunogenicity Study of an Inactivated Hepatitis A Vaccine in Infants and Young Children
Status: Completed
Last Changed: Aug 30, 2012
First Received: Aug 31, 2005
Disease(s): Hepatitis A
Intervention(s): hepatitis A vaccine
Locations: Anchorage Neighborhood Health Center, Anchorage, Alaska, United States
Alaska Native Medical Center, Anchorage, Alaska, United States
A Phase 2b Study in Subjects With Alcoholic Hepatitis to Evaluate Safety and Efficacy of DUR-928 Treatment
Status: Not yet recruiting
Last Changed: Sep 24, 2020
First Received: Sep 24, 2020
Disease(s): Alcoholic Hepatitis
Intervention(s): DUR-928 30 mg, DUR-928 90 mg, Placebo+ Standard of Care (SOC)
Locations: Site 01, Coronado, California, United States
Site 02, Atlanta, Georgia, United States
Biomarkers to Predict the Success of Immunosuppression Withdrawal in Autoimmune Hepatitis
Status: Recruiting
Last Changed: Feb 12, 2020
First Received: Oct 18, 2018
Disease(s): Autoimmune Hepatitis
Intervention(s): Immunosuppression withdrawal
Locations: Hospital Clinic Barcelona, Barcelona, Spain
Hospital del Mar, Barcelona, Spain
Hepatitis c and Vitamin D and Iron Status
Status: Unknown status
Last Changed: May 25, 2017
First Received: May 25, 2017
Disease(s): Hepatitis C
Intervention(s): Sofosbuvir 400 mg, Daclatasvir 60 mg/day
A Phase 3 Study in Combination With BMS-790052 and BMS-650032 in Japanese Hepatitis C Virus (HCV) Patients
Status: Completed
Last Changed: Oct 09, 2015
First Received: Dec 23, 2011
Disease(s): Hepatitis C
Intervention(s): BMS-790052 (Daclatasvir), BMS-650032 (Asunaprevir)
Locations: Local Institution, Nagoya-shi, Aichi, Japan
Local Institution, Chiba-shi, Chiba, Japan
Local Institution, Fukuoka-shi, Fukuoka, Japan
Local Institution, Kurume, Fukuoka, Japan
Local Institution, Ogaki-shi, Gifu, Japan
... and 20 other locations.
Evaluation of the Long-term Persistence of Hepatitis A Antibodies in Healthy Adults Who Were Vaccinated 21-25 Years Earlier With GlaxoSmithKline (GSK) Biologicals' Hepatitis A Vaccine, Havrix®
Status: Withdrawn
Last Changed: Nov 18, 2015
First Received: Apr 28, 2014
Disease(s): Hepatitis A
Intervention(s): Blood sampling
Locations: GSK Investigational Site, Wilrijk, Belgium